Free Trial
→ Ticker Revealed: Pre-IPO Access to 'Next Elon Musk' Company (From Banyan Hill Publishing) (Ad)tc pixel Free BOLT Stock Alerts

Bolt Biotherapeutics (BOLT) Institutional Ownership

Bolt Biotherapeutics logo
$3.50 +0.05 (+1.45%)
Closing price 03:59 PM Eastern
Extended Trading
$3.46 -0.04 (-1.29%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Bolt Biotherapeutics (NASDAQ:BOLT)

Current
Institutional Ownership
Percentage
86.70%
Number of
Institutional Buyers
(last 12 months)
7
Total
Institutional Inflows
(last 12 months)
$759.80K
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$566.97K
Get BOLT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Bolt Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

BOLT Institutional Buying and Selling by Quarter

Bolt Biotherapeutics Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/14/2026Nan Fung Group Holdings Ltd5,000$19.25K0.0%N/A0.260%
5/14/2026Renaissance Technologies LLC77,225$312K0.0%+40.3%4.022%
2/13/2026Vivo Capital LLC72,414$396K0.0%-58.9%3.772%
2/12/2026Renaissance Technologies LLC55,025$301K0.0%+92.2%2.866%
2/11/2026T3 Companies LLC38,000$208K0.3%N/A1.979%
2/6/2026Nano Cap New Millennium Growth Fund L P20,500$112K0.1%N/A1.068%
11/17/2025Susquehanna International Group LLP16,642$89K0.0%N/A0.867%
11/14/2025Shay Capital LLC15,958$85K0.0%N/A0.831%
11/14/2025Squarepoint Ops LLC14,836$79K0.0%+19.8%0.773%
8/15/2025Sofinnova Investments Inc.137,721$795K0.0%-95.0%7.173%
8/14/2025Vivo Capital LLC176,064$986K0.1%-95.0%9.170%
8/14/2025Nan Fung Group Holdings Ltd58,347$337K0.5%-95.0%3.039%
8/11/2025Pfizer Inc31,305$181K0.0%-95.0%1.630%
8/8/2025Geode Capital Management LLC18,533$108K0.0%-95.1%0.965%
7/31/2025Board of Trustees of The Leland Stanford Junior University35,978$208K0.0%-95.0%1.874%
2/17/2025Velan Capital Investment Management LP50,000$27K0.0%N/A0.131%
2/17/2025Squarepoint Ops LLC48,971$26K0.0%N/A0.128%
2/17/2025Millennium Management LLC47,025$25K0.0%N/A0.123%
2/17/2025Citadel Advisors LLC78,961$42K0.0%N/A0.206%
11/16/2024Geode Capital Management LLC352,426$228K0.0%-5.0%0.921%
11/13/2024FMR LLC115,386$75K0.0%+33.2%0.302%
8/9/2024Renaissance Technologies LLC276,739$208K0.0%-46.5%0.726%
8/5/2024Acuitas Investments LLC630,507$473K0.3%+21.7%1.654%
7/18/2024Assenagon Asset Management S.A.34,488$26K0.0%N/A0.090%
2/15/2024Board of Trustees of The Leland Stanford Junior University719,546$806K0.1%-5.0%1.895%
2/7/2024Vivo Capital LLC3,521,291$3.94M0.3%-9.0%9.274%
11/14/2023Newtyn Management LLC1,020,000$1.06M0.3%+2.0%2.688%
7/26/2023Privium Fund Management B.V.116,516$148K0.0%N/A0.308%
7/25/2023Assenagon Asset Management S.A.158,289$203K0.0%-29.9%0.419%
5/8/2023Bailard Inc.28,500$40K0.0%N/A0.075%
2/15/2023Tang Capital Management LLC400,000$520K0.1%+100.0%1.062%
2/14/2023Susquehanna International Group LLP20,307$26K0.0%N/A0.054%
2/8/2023Russell Investments Group Ltd.40,195$52K0.0%-38.2%0.107%
1/12/2023Assenagon Asset Management S.A.225,816$294K0.0%-19.3%0.600%
1/12/2023Marquette Asset Management LLC97,835$127K0.0%+53.4%0.260%
11/15/2022Caas Capital Management LP116,777$173K0.0%N/A0.310%
11/14/2022RA Capital Management L.P.533,432$789K0.0%+18.5%1.417%
11/14/2022Ergoteles LLC88,174$130K0.0%-16.5%0.234%
11/4/2022Russell Investments Group Ltd.64,995$96K0.0%-32.4%0.173%
11/1/2022Privium Fund Management UK Ltd116,516$172K0.2%N/A0.310%
Trump's New Dollar (Ad)

Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel

Watch the free briefing and see the three steps to prepare today
10/18/2022Bailard Inc.46,383$69K0.0%N/A0.123%
7/29/2022Russell Investments Group Ltd.96,100$196K0.0%N/A0.256%
7/27/2022Assenagon Asset Management S.A.275,552$562K0.0%N/A0.735%


BOLT Institutional Ownership - Frequently Asked Questions

During the previous two years, 16 institutional investors and hedge funds held shares of Bolt Biotherapeutics. The most heavily invested institutionals were Sofinnova Investments Inc. ($795K), Vivo Capital LLC ($396K), Renaissance Technologies LLC ($312K), T3 Companies LLC ($208K), Board of Trustees of The Leland Stanford Junior University ($208K), Pfizer Inc ($181K), and Nano Cap New Millennium Growth Fund L P ($112K).Learn more on Bolt Biotherapeutics' institutional investors.

86.70% of Bolt Biotherapeutics' stock is owned by institutional investors. Learn more on BOLT's institutional investor holdings.

Of the 11 institutional investors that purchased Bolt Biotherapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Citadel Advisors LLC ($78.96K), Squarepoint Ops LLC ($51.42K), Velan Capital Investment Management LP ($50K), Renaissance Technologies LLC ($48.60K), Millennium Management LLC ($47.03K), T3 Companies LLC ($38K), and FMR LLC ($28.77K).

Institutional investors have bought a total of 147,148 shares in the last 24 months. This purchase volume represents approximately $759.80K in transactions.

The following institutional investors have sold Bolt Biotherapeutics stock in the last 24 months: Vivo Capital LLC ($103.65K).

Institutional investors have sold a total of 103,650 shares in the last 24 months. This volume of shares sold represents approximately $566.97K in transactions.


Related Companies

Institutional ownership data for NASDAQ:BOLT is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/14/2026. New 13F filings are added each quarter as they're published.
From Our Partners
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...
Porter & Company | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel